Brief: Zydus Lifesciences Launches Semaglutide Injection In Reusable Multi-Dose Pen Device In India, Priced At 2,200 Rupees Per Month
March 20 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS: ZYDUS LIFESCIENCES - LAUNCHES SEMAGLUTIDE INJECTION IN REUSABLE MULTI-DOSE PEN DEVICE IN INDIA ZYDUS LIFESCIENCES - HAS EXCLUSIVE RIGHTS TO REUSABLE PEN DEVICE FOR SEMAGLUTIDE ZYDUS LIFESCIENCES - SEMAGLUTIDE INJECTION PRICED AT 2,200 RUPEES PER MONTH ZYDUS LIFESCIENCES - ZYDUS' SEMAGLUTIDE INJECTION WILL BE AVAILABLE IN 15MG/3ML CARTRIDGE ZYDUS LIFESCIENCES - SEMAGLUTIDE LAUNCHED UNDER SEMAGLYN, MASHEMA, AND ALTERME BRANDS Source text: ID:nBSE3zPPz6 Further company coverage: ZYDU.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zydus Lifesciences
See all newsIndia's Zydus Lifesciences posts lower profit as expenses outpace revenue growth
Brief: Zydus Lifesciences Q2 Consol Net Profit 9.26 Billion Rupees
Brief: Zydus Lifesciences Says Zylidac Bio And Prolific Machines Partner
Brief: Zydus Lifesciences Receives U.S. FDA Approval For Estradiol And Levonorgestrel Transdermal System
Brief: Zydus Lifesciences Says Zydus Sunshine Lifesciences Signs Agreement To Establish A Pharmaceutical Manufacturing Facility In Sri Lanka